Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts

2024/02/10 by Palak J. Trivedi, Palak Trivedi, Gideon M. Hirschfield +3 · 25 citations
Medicine · #Liver Diseases and Immunity #Liver Disease Diagnosis and Treatment #Pediatric Hepatobiliary Diseases and Treatments

paper · pdf · doi:10.1053/j.gastro.2024.01.049

Cited by

• Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale. [europepmc]
• Central role for cholangiocyte pathobiology in cholestatic liver diseases. [europepmc]
• Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology. [europepmc]
• Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis. [europepmc]
• Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review. [europepmc]
• Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. [europepmc]
• Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization. [europepmc]
• Heterogeneity and plasticity of cholangiocytes in liver injury: a journey from pathophysiology to therapeutic utility. [europepmc]
• The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine. [europepmc]
• Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study. [europepmc]
• PARP‑1 in liver diseases: Molecular mechanisms, therapeutic potential and emerging clinical applications (Review). [europepmc]
• Microbial Landscapes of the Gut-Biliary Axis: Implications for Benign and Malignant Biliary Tract Diseases. [europepmc]
• Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases. [europepmc]
• Multi-omics profiling uncovers paradoxical Epstein-Barr virus involvement in autoimmune liver disease pathogenesis. [europepmc]
• Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study. [europepmc]
• Proteomics identifies complement protein signatures in patients with primary biliary cholangitis. [europepmc]
• Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation. [europepmc]
• Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre Study. [europepmc]
• Elevated Serum Soluble Tim-3 in Primary Biliary Cholangitis: Lack of Correlation with Cytokines, Chemokines, and Clinical Parameters. [europepmc]
• Primary sclerosing cholangitis in children: a single-center experience and evaluation of prognostic markers. [europepmc]
• Methodological challenges in mendelian randomization studies of immune cell phenotypes and autoimmune liver diseases. [europepmc]
• Abnormalities of liver sinusoidal endothelial cells in primary biliary cholangitis. [europepmc]
• Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition. [europepmc]
• Ocular surface characteristics and dry eye symptoms in primary biliary cholangitis patients complicated with seasonal allergic conjunctivitis. [europepmc]
• Breaking the metabolo-immune cycle in primary biliary cholangitis for therapeutic benefit. [europepmc]